# OnCo record tumor-associated-macrophages (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/tumor-associated-macrophages/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "tumor-associated-macrophages" ;
  schema:name "Tumour-associated macrophages (TAMs)"@en ;
  schema:description "Tumour-associated macrophages are immune cells that should eat cancer cells but are re-educated by the tumour to protect it instead. They are often the most abundant immune cell in a tumour."@en ;
  schema:url <https://onco.cc/terms/tumor-associated-macrophages/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tumor-associated_macrophage> ;
  owl:sameAs <http://www.wikidata.org/entity/Q17121648> ;
  schema:citation <https://en.wikipedia.org/wiki/Tumor-associated_macrophage> ;
  onco:targets <https://onco.cc/targets/cd47/>, <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/csf1r/>, <https://onco.cc/targets/sirpa/>, <https://onco.cc/targets/cd40/>, <https://onco.cc/targets/mertk/>, <https://onco.cc/targets/cd163/>, <https://onco.cc/targets/cd14/> ;
  onco:drugs <https://onco.cc/drugs/magrolimab/>, <https://onco.cc/drugs/ak117/>, <https://onco.cc/drugs/evorpacept/>, <https://onco.cc/drugs/peluntamig/>, <https://onco.cc/drugs/spevatamig/>, <https://onco.cc/drugs/selicrelumab/>, <https://onco.cc/drugs/mitazalimab/>, <https://onco.cc/drugs/axatilimab/>, <https://onco.cc/drugs/emactuzumab/> ;
  onco:pathways <https://onco.cc/pathways/tumor-microenvironment/>, <https://onco.cc/pathways/myc/> ;
  onco:trials <https://onco.cc/trials/aspen-06/>, <https://onco.cc/trials/nct03424005/>, <https://onco.cc/trials/nct03768063/>, <https://onco.cc/trials/nct04313881/>, <https://onco.cc/trials/nct04675294/>, <https://onco.cc/trials/nct04675333/>, <https://onco.cc/trials/nct04778397/>, <https://onco.cc/trials/nct04888312/>, <https://onco.cc/trials/nct04980885/>, <https://onco.cc/trials/nct05079230/>, <https://onco.cc/trials/nct05227664/>, <https://onco.cc/trials/nct05229497/>, <https://onco.cc/trials/nct05382442/>, <https://onco.cc/trials/nct05482893/>, <https://onco.cc/trials/nct05491226/>, <https://onco.cc/trials/nct05652686/>, <https://onco.cc/trials/nct05849480/>, <https://onco.cc/trials/nct05868226/>, <https://onco.cc/trials/nct06488378/>, <https://onco.cc/trials/nct06601335/>, <https://onco.cc/trials/nct06789848/>, <https://onco.cc/trials/nct06953999/>, <https://onco.cc/trials/nct07007559/>, <https://onco.cc/trials/nct07015853/>, <https://onco.cc/trials/nct07036380/>, <https://onco.cc/trials/nct07199764/>, <https://onco.cc/trials/nct07245446/>, <https://onco.cc/trials/nct07437287/> .
